The World’s Leading Biomanufacturer
undefined
Biological halogenation technology
Core advantages
The global enzyme technology industry market is expanding rapidly, with sales doubling every 5 years and a growth rate of up to 25% to 30%, which is about 10 times the world economic growth rate. 20% of existing human drugs and 25% of drugs under development contain halogens, and 30% of agricultural drugs also contain halogens. Therefore, the synthesis of halides is of great significance in drug development and the pharmaceutical industry.
Currently, only chemical methods can synthesize halides. The Viablife Biolego developed by Weibolai Biotechnology is an international first, which can introduce chlorine and bromine into various structures in a green and environmentally friendly manner, such as macrolides, tetracycline, quinoline, isoquinoline, and plant polyphenolic compounds.
